For the Inventor, By the Inventor

Enter assignee name

Tucson, AZ, United States of America

Research Corporation Technologies, Inc.

USPTO Granted Patents = 366

% Expired Patents = 5.7

CIPO Patents = 41

EPO Patents = 10

Trademarks = 3

Forward Citations = 7,537

Loading Chart...

Loading Chart...

408 inventors (with patents filed for the assignee):

Louis A Carpino (15 out of 26 patents)

Richard Craig (13 out of 27 patents)

Kurt R Gehlsen (12 out of 12 patents)

4. John D Buynak (11 out of 21 patents)

5. William H Pirkle (11 out of 11 patents)

6. Eric T Kool (10 out of 35 patents)

7. Shohei Koide (9 out of 25 patents)

8. David M Center (9 out of 15 patents)

9. Hardy Kornfeld (9 out of 14 patents)

10. William W Cruikshank (8 out of 17 patents)

11. Christopher J Welch (8 out of 8 patents)

12. Thomas G Chappell (7 out of 10 patents)

13. Kevin J Parker (7 out of 36 patents)

14. Arthur G Schwartz (7 out of 14 patents)

15. Robert A Magarian (7 out of 11 patents)

Core Competencies:

Protein Glycosylation

Engineered Polypeptides

Antibody-Like Polypeptides

Pichia Pastoris

Ribotoxin Molecules

Magnetic Resonance Imaging

Cancer Imaging

Gene Therapy

Peptide Synthesis

Fluorescent Nucleoside Analogs

Beta-Lactamase Inhibitors

Viable Gram-Negative Bacteria

366 patents: Sort by Forward Citations

1. 12359211 - Pichia pastoris strains for producing predominantly homogeneous glycan structure (2025-07-15),

2. 11866715 - strains for producing predominantly homogeneous glycan structure (2024-01-09),

3. 11542321 - Engineered stable CH2 polypeptides (2023-01-03),

4. 11220692 - strains for producing predominantly homogeneous glycan structure (2022-01-11),

5. 10829558 - Small antibody-like polypeptides that bind to EPHA2 receptor (2020-11-10),

6. 10612033 - strains for producing predominantly homogeneous glycan structure (2020-04-07),

7. 10370440 - Reconstituted polypeptides (2019-08-06),

8. 10329572 - Pichia pastoris strains for producing predominantly homogeneous glycan structure (2019-06-25),

9. 10113164 - [object Object] (2018-10-30),

10. 9976131 - Ribotoxin molecules derived from sarcin and other related fungal ribotoxins (2018-05-22),

11. 9803210 - Fusion proteins comprising immunoglobulin constant domain-derived scaffolds (2017-10-31),

12. 9617550 - [object Object] (2017-04-11),

13. 9603911 - Ribotoxin molecules derived from sarcin and other related fungal ribotoxins (2017-03-28),

14. 9458454 - Viable gram negative bacteria with reduced proteolytic activity lacking outer membrane agonists of TLR4/MD-2 (2016-10-04),

15. 9359628 - Protein glycosylation modification in methylotrophic yeast (2016-06-07),

Research Corporation Technologies, Inc. is a technology management and investment company that provides support and funding for early-stage technology development. With a focus on commercializing innovative technologies, RCT works with inventors, universities, and research institutions to create successful ventures and bring cutting-edge products to market. Through strategic partnerships and licensing agreements, RCT aims to maximize the value of intellectual property and drive technological advancements across various industries.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Research Corporation Technologies, Inc.

366 Patents

#4 in Tucson, AZ

#13 in Arizona

#1,248 in US

#2,506 in the World

Tucson, AZ, United States of America

Research Corporation Technologies, Inc.

Forward Citations = 7,537

408 inventors:

Louis A Carpino (15 out of 26 patents)

Richard Craig (13 out of 27 patents)

Kurt R Gehlsen (12 out of 12 patents)

4. John D Buynak (11 out of 21 patents)

5. William H Pirkle (11 out of 11 patents)

Please report any incorrect information to [email protected]

Loading…